Specialized Intervention to Protect Central Vision in Diabetic Patients at Erdem Hospital

Diabetic Macular Edema (DME) is the leading cause of severe vision loss in people with diabetes, particularly in working-age adults. DME is a complication of Diabetic Retinopathy caused by the accumulation of fluid in the macula, the central part of the retina responsible for sharp, detailed vision. This swelling damages the macula and can make it impossible to focus clearly, affecting the ability to read, drive, or see faces.

At Erdem Hospital, our specialized Retina and Vitreous Diseases unit provides advanced, prompt diagnosis and multimodal treatment for DME. We prioritize rapid intervention to reduce swelling and stabilize central vision, utilizing cutting-edge diagnostic technology like Optical Coherence Tomography (OCT) to measure retinal thickness.

For patients requiring the frequent and often costly treatments necessary for DME (such as Intravitreal Anti-VEGF Injections), Turkey offers world-class care and the latest medications at significantly reduced costs. This affordability ensures consistent, timely treatment, which is crucial for preserving long-term vision.

Symptoms, Causes, and Risk Factors

DME often has no symptoms in the early stages. Symptoms develop as fluid builds up over weeks to months:

• Blurred Vision or Double Vision.
• Objects Changing Size or Colors Appearing Dull/Faded.
• Straight lines appearing curved or wavy (Metamorphopsia).
• Gaps or Dark Spots appearing in central vision.

Key Risk Factors for developing or worsening DME are strongly tied to systemic health:

• Poor Glycemic Control (High HbA1c): The most important factor.
• High Blood Pressure and High Cholesterol (Dyslipidemia).
• Duration of Diabetes (risk increases with time).
• Smoking and Kidney Disease (Nephropathy).

Advanced Treatment Options

Successful management requires controlling the underlying diabetes and directly treating the retinal swelling.

1. Systemic Management (First Line): Strict glucose (blood sugar) control, managing blood pressure, and lowering cholesterol are essential to reduce the risk of DME progression.
2. Intravitreal Anti-VEGF Injections: The recommended first-line therapy for center-involving DME. Medications are injected directly into the eye to block the Vascular Endothelial Growth Factor (VEGF), reducing blood vessel leakage and swelling. This often leads to improved vision and reduced retinal thickness.
3. Steroid Treatment: Slow-release steroid implants (e.g., Dexamethasone) can be injected into the eye to reduce inflammation and help decrease macular swelling.
4. Laser Treatment (Focal/Grid Photocoagulation): Used to seal specific leaking blood vessels in the macula. Laser may be used regionally in conjunction with injections or for specific types of DME.
5. Vitrectomy Surgery: Required in advanced cases where scar tissue from Proliferative Diabetic Retinopathy (PDR) pulls on the retina or when there is persistent bleeding that does not clear.

What's Included in the DME Treatment Journey

A comprehensive package ensures efficient, ongoing care for this chronic condition:

• VIP airport-hotel-hospital transfers so you're never navigating on your own.
• A three-night stay in premium accommodation (longer stays or hospitalization may be required for surgery).
• Pre-treatment consultation and advanced diagnostic assessments (OCT for thickness measurement and Fluorescein Angiography).
• The chosen treatment (e.g., Anti-VEGF Injection series or Focal Laser).
• A full aftercare kit with any required medications or drops.
• One year follow-up support to monitor OCT and guide the necessary ongoing injection schedule.
• English-speaking staff and interpreters so nothing gets lost in translation.

Treatment Prices Compare

Turkey is a leading destination for cost-effective DME treatment, which often requires multiple injections per year.

• Intravitreal Anti-VEGF Injections in Turkey are significantly more affordable, typically ranging from $400 to $700 per injection.
• This offers substantial savings compared to the US and Europe, ensuring patients can adhere to the frequent injection protocol necessary to prevent blindness.

Frequently Asked Questions

• How many Anti-VEGF injections are typically required in the first year?
• What is the importance of the HbA1c level in DME progression?
• What is the difference between Anti-VEGF and Steroid Implants for DME?
• Will I need to stop taking my diabetes medication before the eye injection?
• Can DME be treated with laser only?
• Does Vitrectomy cure DME?
• What are the side effects of Intravitreal Injections?
• How long does the vision improvement last after treatment?
• Can DME lead to tractional retinal detachment?

Restoring Confidence Through Specialized Retinal Care

DME is a critical consequence of diabetes that demands prompt and consistent management. At Erdem Hospital, we offer world-class, affordable expertise to stabilize the macula and protect your central vision. With 37 years of experience in patient care, our retina specialists ensure you receive precise diagnostics and effective treatment, giving you confidence in managing your sight alongside your systemic health.